The phosphatidylinositol signalling system in elongating bovine blastocysts; formation of phosphoinositides, inositol phosphates and stimulation by growth factors.
The uptake of myo-inositol and its incorporation into the phosphoinositides and inositol phosphates of the phosphatidylinositol (PtdIns) signal transduction system by in vivo elongating cattle blastocysts was investigated using [3H]myo-inositol. Uptake was examined in 13-, 14- and 16-day-old blastocysts and was largely sodium-dependent throughout (P<0.001), indicating the presence of a sodium-dependent inositol transporter. Incorporation of inositol into the three phosphoinositides, PtdIns, PtdInsP and PtdInsP2, and the inositol phosphates of the phosphatidylinositol signal transduction system was examined at Days 14 and 16; incorporation into the three phosphoinositides and into the inositol phosphate species, InsP1, InsP2, InsP3 (including the second messenger, Ins(1,4,5)P3) and InsP4 was detected in both blastocyst stages. The effects of the peptide growth factor, epidermal growth factor (EGF), and the lipid growth factors, lysophosphatidic acid (LPA) and platelet activating factor (PAF), on the activity of the phosphatidylinositol signalling system in 14- and 16-day-old blastocysts were examined. All growth factors significantly stimulated phosphatidylinositol signalling activity. Epidermal growth factor was stimulatory (P<0.001) only in 16-day-old blastocysts, whereas LPA and PAF were active in both 14- (P<0.005 for LPA and P<0.001 for PAF) and 16-day-old blastocysts (P<0.001 for LPA and PAF). These results indicate that the phosphatidylinositol signalling system is present in cattle blastocysts at the elongation stage and is responsive to stimulation by growth factors.
Hynes
A C
AC
Department of Physiology, National University of Ireland, Galway, University Road, Galway, Ireland.
Sreenan
J M
JM
Kane
M T
MT
D000818:Animals; D001755:Blastocyst / Q000187:drug effects / Q000378:metabolism*; D002417:Cattle / Q000196:embryology*; D004815:Epidermal Growth Factor / Q000494:pharmacology; D006133:Growth Substances / Q000494:pharmacology*; D007294:Inositol / Q000378:metabolism; D007295:Inositol Phosphates / Q000096:biosynthesis*; D008246:Lysophospholipids / Q000494:pharmacology; D010716:Phosphatidylinositols / Q000096:biosynthesis* / Q000378:metabolism*; D010972:Platelet Activating Factor / Q000494:pharmacology; D015398:Signal Transduction; D012964:Sodium / Q000494:pharmacology; D014316:Tritium; D010738:Type C Phospholipases / Q000378:metabolism
D006133:Growth Substances; D007295:Inositol Phosphates; D008246:Lysophospholipids; D010716:Phosphatidylinositols; D010972:Platelet Activating Factor; D014316:Tritium; D007294:Inositol; D004815:Epidermal Growth Factor; D012964:Sodium; D010738:Type C Phospholipases; C032881:lysophosphatidic acid